-
1
المؤلفون: Wierda, W. G., Allan, J. N., Siddiqi, T., Kipps, T. J., Opat, S., Tedeschi, Alessandra, Badoux, X. C., Kuss, B. J., Jackson, S., Moreno, Carol, Jacobs, R. M. D., Pagel, J. M., Flinn, I., Pak, Y., Zhou, Cathy, Szafer-Glusman, E., Ninomoto, J., Dean, James P, James, D. F., Ghia, Paolo, Tam, C. S., Universitat Autònoma de Barcelona
المساهمون: Wierda, William G, Allan, John N, Siddiqi, Tanya, Kipps, Thomas J, Opat, Stephen, Tedeschi, Alessandra, Badoux, Xavier C, Kuss, Bryone J, Jackson, Sharon, Moreno, Carol, Jacobs, Ryan, Pagel, John M, Flinn, Ian, Pak, Yvonne, Zhou, Cathy, Szafer-Glusman, Edith, Ninomoto, Joi, Dean, James P, James, Danelle F, Ghia, Paolo, Tam, Constantine S
المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol 39, iss 34
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
JOURNAL OF CLINICAL ONCOLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instnameمصطلحات موضوعية: Male, Oncology, Cancer Research, Neoplasm, Residual, Lymphoma, Chronic lymphocytic leukemia, Phases of clinical research, Cohort Studies, chemistry.chemical_compound, Piperidines, Antineoplastic Combined Chemotherapy Protocols, Medicine, Chronic, Cancer, Sulfonamides, Leukemia, Heterocyclic, Hematology, Middle Aged, Lymphocytic, Residual, 6.1 Pharmaceuticals, Ibrutinib, Cohort, Female, Adult, medicine.medical_specialty, Clinical Trials and Supportive Activities, Clinical Sciences, Oncology and Carcinogenesis, Bridged Bicyclo Compounds, Rare Diseases, Clinical Research, Internal medicine, Humans, Oncology & Carcinogenesis, Aged, business.industry, Venetoclax, Adenine, B-Cell, Evaluation of treatments and therapeutic interventions, Bridged Bicyclo Compounds, Heterocyclic, medicine.disease, Leukemia, Lymphocytic, Chronic, B-Cell, Survival Analysis, Minimal residual disease, Discontinuation, First line treatment, Orphan Drug, chemistry, Neoplasm, business
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c35a6a06435710a766e71312c7d53b84
https://doi.org/10.1200/jco.21.00807 -
2
المؤلفون: Bryone J. Kuss, Ian W. Flinn, Paolo Ghia, Juthamas Sukbuntherng, Ahmed Salem, John N. Allan, Paul M. Barr, Ryan Jacobs, Cathy Zhou, Alessandra Tedeschi, Xavier Badoux, Constantine S. Tam, Karl Eckert, Danelle F. James, Tanya Siddiqi, William G. Wierda, Stephen Opat, Thomas J. Kipps, Joi Ninomoto, Kristin Russell
المساهمون: Tam, C. S., Siddiqi, T., Allan, J. N., Kipps, T. J., Flinn, I. W., Kuss, B. J., Opat, S., Barr, P. M., Tedeschi, A., Jacobs, R., Badoux, X. C., Ghia, P., Sukbuntherng, J., Salem, A. H., Russell, K., Eckert, K., Zhou, C., Ninomoto, J., James, D. F., Wierda, W. G.
مصطلحات موضوعية: 0301 basic medicine, Immunology, Disease progression, Stock options, Cell Biology, Hematology, Biochemistry, Small cell lymphoma, Lymphocytic lymphoma, Management, First line treatment, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Disease remission, Honorarium, Business, Protein p53, 030215 immunology
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a44e9f5ae70f78fa9be8e5498cd2cacf